Drug(s) | Indication | Phase | Status | Location(s) | Identifier |
---|---|---|---|---|---|
Inebilizumab, placebo | Neuromyelitis optica spectrum disorder | II/III | Completed | Multinational |
EudraCT2014-000253-36 N-MOmentum CD-IA-MEDI-551-1155 |
Inebilizumab, VIB4920 | Kidney transplant desensitization | II | Active (not recruiting) | USA |
VIB0551.P2.S1 |